Therapeutic targeting of hepatic macrophages for the treatment of liver diseases

D van der Heide, R Weiskirchen, R Bansal - Frontiers in immunology, 2019 - frontiersin.org
Hepatic macrophages play a central role in maintaining homeostasis in the liver, as well as
in the initiation and progression of liver diseases. Hepatic macrophages are mainly derived …

Targeting of hepatic macrophages by therapeutic nanoparticles

CI Colino, JM Lanao, C Gutierrez-Millan - Frontiers in immunology, 2020 - frontiersin.org
Hepatic macrophage populations include different types of cells with plastic properties that
can differentiate into diverse phenotypes to modulate their properties in response to different …

Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis

SA Polyzos, ES Kang, C Boutari, EJ Rhee… - Metabolism, 2020 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent disease and important unmet
medical need. Current guidelines recommend, under specific restrictions, pioglitazone or …

Immunomodulatory nanosystems for treating inflammatory diseases

N Ahamad, A Kar, S Mehta, M Dewani, V Ravichandran… - Biomaterials, 2021 - Elsevier
Inflammatory disease (ID) is an umbrella term encompassing all illnesses involving chronic
inflammation as the central manifestation of pathogenesis. These include, inflammatory …

[HTML][HTML] Multiple mechanisms of curcumin targeting spinal cord injury

G Gu, J Ren, B Zhu, Z Shi, S Feng, Z Wei - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Spinal cord injury (SCI) is an irreversible disease process with a high disability and mortality
rate. After primary spinal cord injury, the secondary injury may occur in sequence, which is …

The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State‐of‐the‐Art Review

SA Moosavian, T Sathyapalan… - Bioinorganic …, 2021 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease that can lead to
end‐stage liver disease needing a liver transplant. Many pharmacological approaches are …

Design of hepatic targeted drug delivery systems for natural products: insights into nomenclature revision of nonalcoholic fatty liver disease

R Tang, R Li, H Li, XL Ma, P Du, XY Yu, L Ren… - Acs Nano, 2021 - ACS Publications
Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic-dysfunction-
associated fatty liver disease (MAFLD), affects a quarter of the worldwide population. Natural …

Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches

E Conte - Pharmacology & Therapeutics, 2022 - Elsevier
Over almost 140 years since their identification, the knowledge about macrophages has
unbelievably evolved. The'big eaters' from being thought of as simple phagocytic cells have …

Advancements in macrophage-targeted drug delivery for effective disease management

H Liu, H Lv, X Duan, Y Du, Y Tang… - International Journal of …, 2023 - Taylor & Francis
Macrophages play a crucial role in tissue homeostasis and the innate immune system. They
perform essential functions such as presenting antigens, regulating cytokines, and …

[HTML][HTML] PD-L1–and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease

R Galea, HJ Nel, M Talekar, X Liu, JD Ooi, M Huynh… - JCI insight, 2019 - ncbi.nlm.nih.gov
Autoimmune diseases resulting from MHC class II–restricted autoantigen-specific T cell
immunity include the systemic inflammatory autoimmune conditions rheumatoid arthritis and …